Abiopharma

🔍 Reeder David (Director)

Company: ENTEGRIS INC (ENTG)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 38,750 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 97,207.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest as follows: 25% of the RSUs vest on April 5, 2027, and the remaining 75% of the RSUs vest in equal quarterly installments over the three year period thereafter.
• F2: Awarded pursuant to the Entegris, Inc. 2020 Stock Plan in consideration of services as an employee.